Back to top
more

Mallinckrodt public limited company (MNK)

(Delayed Data from NYSE)

$16.14 USD

16.14
1,972,598

+0.44 (2.80%)

Updated May 3, 2019 04:02 PM ET

After-Market: $16.14 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

Brian Bolan headshot

The Short Playbook on TSLA, HLF and QCOR

A look at a common theme on three battleground stocks where shorts have been crushed.

    Should Value Investors Consider Mallinckrodt (MNK) Stock?

    Is Mallinckrodt (MNK) a great pick from the value investor's perspective right now? Read on to know more.

      MedTech Overcomes Policy Hurdles, Long-Term Prospects Bright

      With the suspension of the controversial 2.3% medical device tax for another two years, the medical device industry is currently riding high on optimism.

        Mallinckrodt PLC (MNK) Jumps: Stock Rises 15.3%

        Mallinckrodt PLC (MNK) shares rose more than 15% in the last trading session, amid huge volumes.

          Are Options Traders Betting on a Big Move in Mallinckrodt (MNK) Stock?

          Investors need to pay close attention to Mallinckrodt (MNK) stock based on the movements in the options market lately.

            Lam Research, Mallinckrodt, Texas Instruments, Vishay Intertechnology and Marvell Technology highlighted as Zacks Bull and Bear of the Day

            Lam Research, Mallinckrodt, Texas Instruments, Vishay Intertechnology and Marvell Technology highlighted as Zacks Bull and Bear of the Day

              Kevin Cook headshot

              Bear of the Day: Mallinckrodt PLC (MNK)

              Generic drug makers are one of the worst performing industries this year and there's little sign of a turnaround

                Ekta Bagri headshot

                Mallinckrodt (MNK) Tops Q2 Earnings, Misses on Sales

                Mallinckrodt plc (MNK) beat earnings estimates in the second quarter but sales fell short due to weakness in generics segment.

                  Why Mallinckrodt (MNK) Might Surprise This Earnings Season

                  Mallinckrodt (MNK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

                    Is Mallinckrodt (MNK) a Great Stock for Value Investors?

                    Value investing is easily one of the most popular ways to find great stocks in any market environment.

                      Mallinckrodt (MNK) Down 10% Since Earnings Report: Can It Rebound?

                      MNK reported earnings 30 days ago. What's next for the company? We take a look at earnings estimates for some clues.

                        Madeleine Johnson headshot

                        Here's Why Mallinckrodt (MNK) Shares are Lower Today

                        On Monday, shares of pharmaceutical company Mallinckrodt Plc. (MNK) are slipping, down about 5% to $40.50 per share in afternoon trading--MNK dropped about 8% in heavy morning trading--after a new report from short-seller Citron Research targeted the company.

                          Mallinckrodt (MNK) Tops Q1 Earnings, Sales

                          Mallinckrodt beats on earnings and sales in the first quarter.

                            Mallinckrodt (MNK) Tops on Earnings in Transition Quarter

                            Mallinckrodt Public Limited Company (MNK) reported positive results for the transition quarter (Oct 1, to Dec 30, 2016) beating both sales and earnings expectations.

                              Ekta Bagri headshot

                              Mallinckrodt (MNK) Tops Earnings & Sales Estimates

                              Mallinckrodt beats both earnings and sales expectations in the transition quarter.

                                David Bartosiak headshot

                                Bartosiak: Trading Mallinckrodt's (MNK) Earnings with Options

                                Join Dave Bartosiak at 9:00am Central Time on Friday, February 3rd, to see his thoughts on Mallinckrodt (MNK) before they report earnings with real-time options insight.

                                  Mallinckrodt to Sell Intrathecal Therapy Business for $203M

                                  Mallinckrodt plc (MNK), entered into an agreement to sell its Intrathecal Therapy business for approximately $203 million with Piramal.

                                    Is Mallinckrodt (MNK) a Top Choice for Value Investors?

                                    Let's find out if Mallinckrodt Public Limited Company (MNK) stock is a good choice for value-oriented investors.

                                      Mallinckrodt to Pay $100M Fine to FTC for Questcor Matter

                                      Mallinckrodt plc (MNK), will have to pay a fine of $100 million to the U.S. Federal Trade Commission (FTC) to resolve the latter???s investigation into the acquisition of Synacthen Depot by its Questcor division.

                                        Sheraz Mian headshot

                                        Research Reports for Amazon, IBM, Cisco & others

                                        Today's must-read reports are for Amazon.com (AMZN), Visa (V) and Mallinckrodt (MNK).